Altered Resting-state Connectivity in Huntington's Disease
Overview
Authors
Affiliations
Huntington's disease (HD) is an autosomal dominantly inherited neurodegenerative disorder characterized by motor, cognitive, and psychiatric symptoms. Using resting-state fMRI (rs-fMRI) we investigated the functional integrity of resting-state networks (RSN) in HD. 17 HD and 19 matched control participants were examined at a 3 Tesla MR scanner. After controlling for structural degeneration by means of voxel-based morphometry, task-free rs-fMRI data were analyzed using Independent Component Analysis (ICA) and a dual-regression approach in the context of genetic and clinical parameters. Further, we evaluated HD-related differences in interregional connectivity between networks. RSN analysis showed a significant increase in intrinsic functional connectivity in the HD sample compared with controls, including the thalamus, striatum, prefrontal, premotor, and parietal maps. A subset of the Default Mode Network (DMN) was also affected. In the HD cohort, motor impairment correlated with higher network connectivity in mainly motor and parietal cortices. Deteriorating total functional capacity was additionally associated with higher connectivity in the striatum, thalamus, insular and frontal areas. This pattern of increased activity in intrinsic functional networks might suggest a reduced ability of intra-network differentiation with clinical disease progression in HD. Finally, results showed reduced long-range connectivity between parietal ICA components in HD compared to controls, indicating impaired functional coupling between interregional networks in HD. Our data demonstrates that functional connectivity is profoundly altered in HD, both within and between RSN. Rs-fMRI analysis may provide additional valuable insights into neuronal dysfunctions beyond HD-related structural degeneration and disruptions of functional circuits in HD.
Advanced Magnetic Resonance Imaging for Early Diagnosis and Monitoring of Movement Disorders.
Ortega-Robles E, de Celis Alonso B, Cantillo-Negrete J, Carino-Escobar R, Arias-Carrion O Brain Sci. 2025; 15(1).
PMID: 39851446 PMC: 11763950. DOI: 10.3390/brainsci15010079.
Kim L, Kundu B, Moretti P, Lozano A, Rahimpour S Neurotherapeutics. 2024; 21(6):e00452.
PMID: 39304438 PMC: 11585891. DOI: 10.1016/j.neurot.2024.e00452.
Nietz A, Popa L, Carter R, Gerhart M, Manikonda K, Ranum L bioRxiv. 2024; .
PMID: 38948725 PMC: 11212952. DOI: 10.1101/2024.06.20.599947.
The contribution of preclinical magnetic resonance imaging and spectroscopy to Huntington's disease.
Perot J, Brouillet E, Flament J Front Aging Neurosci. 2024; 16:1306312.
PMID: 38414634 PMC: 10896846. DOI: 10.3389/fnagi.2024.1306312.
Maggio M, Billeri L, Cardile D, Quartarone A, Calabro R Biomedicines. 2024; 12(1).
PMID: 38255146 PMC: 10813604. DOI: 10.3390/biomedicines12010039.